A Novel Antihepatitis Drug, Bicyclol, Prevents Liver Carcinogenesis in Diethylnitrosamine-Initiated and Phenobarbital-Promoted Mice Tumor Model

Bicyclol, an antihepatitis drug developed by Chinese scientists, has been shown to prevent the malignant transformation induced by 3-methylcholanthrene and 12-O-tetradecanoylphorbol-13-acetate in WB-F344 rat liver epithelial cells. This study provides further evidence on its role as a chemopreventiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hua, Yu, Linghong, Wei, Huailing, Liu, Gengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303747/
https://www.ncbi.nlm.nih.gov/pubmed/22500097
http://dx.doi.org/10.1155/2012/584728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303747/
https://www.ncbi.nlm.nih.gov/pubmed/22500097
http://dx.doi.org/10.1155/2012/584728

Ejemplares similares